Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis

S. A. Harrison, S. R. Marri, N. Chalasani, R. Kohli, W. Aronstein, G. A. Thompson, W. Irish, M. V. Miles, S. A. Xanthakos, E. Lawitz, M. Noureddin, T. D. Schiano, M. Siddiqui, A. Sanyal, B. A. Neuschwander-Tetri, P. G. Traber

Research output: Contribution to journalArticle

52 Scopus citations

Fingerprint Dive into the research topics of 'Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences